EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

Dupilumab treatment effectively reduces nasal type 2 cytokine production following acetylsalicylic acid provocation in N-ERD patients

Sunday 02 Jun, 17:21 PM - 17:33 PM Valencia, Spain